Search Results - Michel Klein

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Is a multivalent hand, foot, and mouth disease vaccine feasible?

    Is a multivalent hand, foot, and mouth disease vaccine feasible? by Michel Klein, Pele Chong

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Intelligent mobile support for therapy adherence and behavior change

    Intelligent mobile support for therapy adherence and behavior change by Michel Klein, Nataliya Mogles, Arlette van Wissen

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Digital Health Behavior Change Technology: Bibliometric and Scoping Review of Two Decades of Research

    Digital Health Behavior Change Technology: Bibliometric and Scoping Review of Two Decades of Research by Fawad Taj, Michel Klein, Aart van Halteren

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    What technological features are used in smartphone apps that promote physical activity? A review and content analysis

    What technological features are used in smartphone apps that promote physical activity? A review and content analysis by Julia S. Mollee, Anouk Middelweerd, Roel Kurvers, Michel Klein

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Empowering vulnerable target groups with serious games and gamification

    Empowering vulnerable target groups with serious games and gamification by Laura M. van der Lubbe, Charlotte Gerritsen, Michel Klein, Koen V. Hindriks

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Augmentation of Human Influenza A Virus-Specific Cytotoxic T Lymphocyte Memory by Influenza Vaccine and Adjuvanted Carriers (ISCOMS)

    Augmentation of Human Influenza A Virus-Specific Cytotoxic T Lymphocyte Memory by Influenza Vaccine and Adjuvanted Carriers (ISCOMS) by Francis A. Ennis, John Cruz, Julie Jameson, Michel Klein, David S. Burt, John Thipphawong

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1

    Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1 by Min Jiang, Johnson Mak, Alim Ladha, Éric A. Cohen, Michel Klein, Benjamin Rovinski, Lawrence Kleiman

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Expanded child support grant eligibility and later-life mortality among mothers in rural South Africa

    Expanded child support grant eligibility and later-life mortality among mothers in rural South Africa by Rishika Chakraborty, Erika T. Beidelman, Michel Klein, Lindsay C. Kobayashi, Katherine Eyal, Chodziwadziwa Kabudula, Molly Rosenberg

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The crystal structure of pertussis toxin

    The crystal structure of pertussis toxin by Penelope E. Stein, Amechand Boodhoo, Glen D. Armstrong, Stephen A. Cockle, Michel Klein, Randy J. Read

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Stem‐Cell Clinging by a Thread: AFM Measure of Polymer‐Brush Lateral Deformation

    Stem‐Cell Clinging by a Thread: AFM Measure of Polymer‐Brush Lateral Deformation by Michel Klein Gunnewiek, Shivaprakash N. Ramakrishna, Andrea Di Luca, G. Julius Vancsó, Lorenzo Moroni, Edmondo M. Benetti

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Covalent Binding of Bone Morphogenetic Protein‐2 and Transforming Growth Factor‐β3 to 3D Plotted Scaffolds for Osteochondral Tissue Regeneration

    Covalent Binding of Bone Morphogenetic Protein‐2 and Transforming Growth Factor‐β3 to 3D Plotted Scaffolds for Osteochondral Tissue Regeneration by Andrea Di Luca, Michel Klein‐Gunnewiek, G. Julius Vancsó, Clemens van Blitterswijk, Edmondo M. Benetti, Lorenzo Moroni

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    The Transferrin Binding Protein B of <i>Moraxella catarrhalis</i> Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen

    The Transferrin Binding Protein B of <i>Moraxella catarrhalis</i> Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen by Lisa E. Myers, Yanping Yang, Run-Pan Du, Qijun Wang, Robin E. Harkness, Anthony B. Schryvers, Michel Klein, Sheena M. Loosmore

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Protection against Respiratory Syncytial Virus Infection by DNA Immunization

    Protection against Respiratory Syncytial Virus Infection by DNA Immunization by Xiaomao Li, Suryaprakash Sambhara, Cindy Xin Li, M. Ewasyshyn, Mark Parrington, Judy Caterini, Olive James, G A Cates, Run-Pan Du, Michel Klein

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system

    Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system by Ariane Höer, G. Schiffhorst, Anne Zimmermann, Johann Fischaleck, L Gehrmann, H Ahrens, Günther Carl, Karl-Otto Sigel, Ulrike Osowski, Michel Klein, Hans-Holger Bleß

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Production of EV71 vaccine candidates

    Production of EV71 vaccine candidates by Pele Chong, Shih‐Yang Hsieh, Chia‐Chyi Liu, Ai‐Hsiang Chou, Jui-Yuan Chang, Suh‐Chin Wu, Shih‐Jen Liu, Yen‐Hung Chow, Ih‐Jen Su, Michel Klein

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeficiency Virus Type 1-Infected Patients Treated with Prolonged Highly Active Antiretroviral Therapy

    Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeficiency Virus Type 1-Infected Patients Treated with Prolonged Highly Active Antiretroviral... by Xia Jin, Murugappan Ramanathan, Shady Barsoum, Georges Deschênes, Lei Ba, James Μ. Binley, Daryl S. Schiller, Daniel Bauer, Donald C. Chen, Arlene Hurley, L. Gebuhrer, Raphaëlle El Habib, Pierre Caudrelier, Michel Klein, Linqi Zhang, David D. Ho, Martin Markowitz

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with <i>Mycobacterium tuberculosis</i>

    Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with <i>Mycobacterium tuberculosis</i> by Abebech Demissie, Eliane M.S. Leyten, Markos Abebe, Liya Wassie, Abraham Aseffa, Getahun Abate, Helen A. Fletcher, Patrick K. Owiafe, Philip C. Hill, Roger H. Brookes, G.A.W. Rook, Alimuddin Zumla, Sandra M. Arend, Michel Klein, Tom H. M. Ottenhoff, Peter Andersen, T. Mark Doherty

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    ALVAC-SIV-<i>gag</i>-<i>pol</i>-<i>env</i>-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIV<sub>mac</sub>-Induced Immunodeficiency

    ALVAC-SIV-<i>gag</i>-<i>pol</i>-<i>env</i>-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIV<sub>mac</sub>-Induc... by R Pal, David Venzon, Norman L. Letvin, Sampa Santra, David C. Montefiori, N. R. Miller, Elżbieta Tryniszewska, Mark G. Lewis, Thomas C. VanCott, Vanessa M. Hirsch, Ruth Woodward, Andrew Gibson, Michele Grace, Eric Dobratz, P D Markham, Zdeněk Hel, János Nacsa, Michel Klein, J. Tartaglia, Genoveffa Franchini

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Safety and Immunogenicity of a Canarypox‐Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher‐ and Lower‐Risk Volunteers

    Safety and Immunogenicity of a Canarypox‐Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher‐ and Lower‐Risk Volunteers by Robert B. Belshe, Cladd E. Stevens, Geoffrey J. Gorse, Susan Buchbinder, Kent J. Weinhold, Haynes W. Sheppard, Donald M. Stablein, Steve Self, James McNamara, Sharon E. Frey, Jorge Flores, Jean Louis Excler, Michel Klein, Raphaëlle El Habib, Anne‐Marie Duliège, Clayton Harro, Lawrence Corey, Michael C. Keefer, Mark J. Mulligan, Peter F. Wright, Connie Celum, Frank Judson, Kenneth H. Mayer, David J. McKirnan, Michael Marmor, George Woody

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Real-world nudging, pricing, and mobile physical activity coaching was insufficient to improve lifestyle behaviours and cardiometabolic health: the Supreme Nudge parallel cluster-randomised controlled supermarket trial

    Real-world nudging, pricing, and mobile physical activity coaching was insufficient to improve lifestyle behaviours and cardiometabolic health: the Supreme Nudge parallel cluster-r... by Josine M. Stuber, Joreintje D. Mackenbach, Gert‐Jan de Bruijn, Marleen Gillebaart, Jody C. Hoenink, Cédric N. H. Middel, Denise T. D. de Ridder, Yvonne T. van der Schouw, Edith G. Smit, Elizabeth Velema, Anne L. Vos, Wilma Waterlander, Jeroen Lakerveld, Joline W. J. Beulens, Femke Rutters, Stephanie S. A. H. Blom, Femke E. de Boer, Michel Klein, Jacqueline E. W. Broerse, Tjerk Jan Schuitmaker‐Warnaar, Ivonne Sluijs, Marjolein C. Harbers

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: